Cargando…

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37

PURPOSE: Staphylococcus aureus is the most common persistent pathogen in humans, so development of new formulations to combat pathogen invasion is quite necessary. METHODS: In the current study, for the first time, the synergistic activity of recombinant lysostaphin and LL-37 peptide was studied aga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadeghi, Somayeh, Bakhshandeh, Haleh, Ahangari Cohan, Reza, Peirovi, Afshin, Ehsani, Parastoo, Norouzian, Dariush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911324/ https://www.ncbi.nlm.nih.gov/pubmed/31849468 http://dx.doi.org/10.2147/IJN.S230269

Ejemplares similares

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.
por: Dixon, R. E., et al.
Publicado: (1968)

pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy
por: Khodabakhsh, Farnaz, et al.
Publicado: (2022)

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
por: Bastos, Maria do Carmo de Freire, et al.
Publicado: (2010)

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies.
por: Schaffner, W., et al.
Publicado: (1967)

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
por: Schaffner, W., et al.
Publicado: (1967)

Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
por: Sabala, Izabela, et al.
Publicado: (2012)

In Silico Design and In Vitro Evaluation of Some Novel AMPs Derived From Human LL-37 as Potential Antimicrobial Agents for Keratitis
por: Pashapour, Arsalan, et al.
Publicado: (2022)

Affinity Based Nano-Magnetic Particles for Purification of Recombinant Proteins in Form of Inclusion Body
por: Seyedinkhorasani, Masoud, et al.
Publicado: (2020)

Comparison of E. coli based self-inducible expression systems containing different human heat shock proteins
por: Shariati, Fatemeh Sadat, et al.
Publicado: (2021)

Rapid screening of high expressing Escherichia coli colonies using a novel dicistronic-autoinducible system
por: Shariati, Fatemeh Sadat, et al.
Publicado: (2021)

Antimicrobial peptidase lysostaphin at subinhibitory concentrations modulates staphylococcal adherence, biofilm formation, and toxin production
por: Yue, Yuan, et al.
Publicado: (2023)

Increment in protease activity of Lysobacter enzymogenes strain by ultra violet radiation
por: Kalahroudi, Reyhaneh Jafari, et al.
Publicado: (2020)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans
por: Farhangnia, Leila, et al.
Publicado: (2014)

Clinical efficacy of intravaginal recombinant lysostaphin administration on endometritis in sows
por: Ye, Guizi, et al.
Publicado: (2021)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein
por: Abtahi, Hamid, et al.
Publicado: (2016)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Structural and Functional Insights Into Lysostaphin–Substrate Interaction
por: Tossavainen, Helena, et al.
Publicado: (2018)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Hyaluronic acid production and characterization by novel Bacillus subtilis harboring truncated Hyaluronan Synthase
por: Amjad Zanjani, Fatemeh Sadat, et al.
Publicado: (2022)

Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014)

Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal Skin Infection
por: Sangboonruang, Sirikwan, et al.
Publicado: (2021)

Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy
por: Alemi, Ashraf, et al.
Publicado: (2018)

Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology
por: Aghaabdollahian, Safieh, et al.
Publicado: (2019)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin
por: Grishin, Alexander V., et al.
Publicado: (2019)

A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity
por: Grishin, Alexander V., et al.
Publicado: (2020)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
por: Hwang, Young Ji, et al.
Publicado: (2014)

LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure
por: Sol, Asaf, et al.
Publicado: (2012)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hmdkiqg2lobhqevg9eh7oo4tum